Biotech

All Articles

Biogen cans SAGE-324 partnership after vital trembling stop working

.Biogen has carried out the final rites to its own cooperation with Sage Therapies on SAGE-324, brea...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion ratings

.On the exact same time that some Parkinson's illness medications are being actually cast doubt on, ...

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Life Sciences, Arc Venture Allies is actually pro...

Orion to make use of Aitia's 'digital identical twins' to locate brand new cancer drugs

.Finnish biotech Orion has snooped possible in Aitia's "electronic double" specialist to cultivate b...

Windtree's surprise med rears high blood pressure in most recent stage 2 win

.While Windtree Rehabs has strained to expand the financial origins needed to survive, a stage 2 win...

2 cancer biotechs merge, generating international footprint

.OncoC4 is actually taking AcroImmune-- as well as its internal scientific manufacturing abilities--...

Amgen records 1st phase 3 win for $400M dermatitis medication

.Amgen has shared (PDF) the 1st stage 3 information on its $400 million eczema drug, linking the ant...

Biogen, UCB file stage 3 lupus gain after falling short earlier trial

.Biogen as well as UCB's depend improving right into phase 3 astride an unsuccessful research hopes ...

Aptadir wishes brand-new RNA preventions can reverse complicated cancers cells

.Italian biotech Aptadir Therapies has actually released with the promise that its pipe of preclinic...

Wave surfs DMD excellence to regulators' doors, delivering stock up

.Surge Lifestyle Sciences has satisfied its objective in a Duchenne muscle dystrophy (DMD) research,...